The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Octreotide 500 micrograms/1 ml Solution for Injection

500 microgram(s)/millilitre Solution for injection

Pfizer Healthcare IrelandPA0822/218/004

Main Information

Trade NameOctreotide 500 micrograms/1 ml Solution for Injection
Active SubstancesOCTREOTIDE ACETATE
Strength500 microgram(s)/millilitre
Dosage FormSolution for injection
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/218/004

Group Information

ATC CodeH01CB Somatostatin and analogues
H01CB02 octreotide

Status

Authorised/WithdrawnAuthorised
Licence Issued22/06/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back